November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Genetic Variation Linked to Dosing Differences for Transplant Medication in Children

❤️ Conditions & Care 2 min read 👁 7

A new study reveals that specific genetic variations significantly influence how pediatric heart transplant patients process the vital immunosuppressant drug tacrolimus.

Genetic Variation Linked to Dosing Differences for Transplant Medication in Children❤️Conditions & Care

Photo: Nature Health Sciences

Key points

  • Children with the CYP3A5*1 allele required a 2.7-fold higher dose of tacrolimus.
  • Metabolite concentrations were lower in patients carrying the CYP3A5*1 allele.
  • Larger studies are needed to establish routine genetic-guided dosing protocols.

Researchers investigating the pharmacokinetics of tacrolimus in pediatric heart transplant recipients have found that genetic differences in the CYP3A5 enzyme heavily affect medication requirements. Published in Nature Health Sciences, the study analyzed saliva and whole blood samples from 64 children who had undergone heart transplantation to better understand why patients process the anti-rejection drug at varying rates.

The findings indicate that young patients carrying the CYP3A5*1 allele required a 2.7-fold higher dose of tacrolimus compared to those with the CYP3A5*3/*3 genotype. Furthermore, weight-adjusted dose-normalized concentrations of both the parent medication and its M-I and M-II metabolites were notably lower among children possessing the CYP3A5*1 allele. Tacrolimus remains a primary immunosuppressive agent used to prevent organ rejection after solid organ transplantation, but it is known for a narrow therapeutic window and substantial variability between patients.

While the study demonstrates a clear link between the CYP3A5 genotype and drug pharmacokinetics, the authors emphasize that larger studies are necessary to confirm its ultimate clinical importance. Because the research relied on an observational cohort of 64 pediatric patients and genetic-guided dosing is not yet widely implemented in routine clinical practice, these findings highlight early-stage evidence rather than an immediate change in medical guidelines. Pediatric patients possess unique physiological factors, such as age-based maturation and fluid load shifts, that separate them from adult or kidney and liver transplant populations.

What to know: Children with the CYP3A5*1 genetic variant needed higher doses of the anti-rejection drug tacrolimus, suggesting that future dosing strategies might benefit from genetic profiling. Always consult a qualified healthcare provider regarding personal medical decisions and treatment plans.

Source Nature Health Sciences — nature.com/articles/s41397-026-00435-z ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.